Twist Bioscience Price Target Cut to $137.00/Share From $190.00 by TD Cowen

What happened

TD Cowen cut its price target for Twist Bioscience to $137.00 per share from $190.00 per share. The article also says TD Cowen maintained its Buy rating on the company; it provides no explanation for either action.

Confirmed

Global impact / market context

A lower price target signals that TD Cowen sees less potential value per share than before, while maintaining a Buy rating indicates it still recommends buying the stock. The article gives no reasoning, so it does not show what changed in the company’s outlook.

Analyst inference

Analyst targets are opinions, not company results or guarantees of future share prices. Here, the target was reduced but the Buy rating stayed in place; without an explanation or financial details, the article does not establish any change in Twist Bioscience’s revenue, costs, or capital spending.

Analyst inference

What to watch

1. Look for TD Cowen’s explanation of the lower target, including whether it reflects changed expectations for sales, costs, or the value assigned to future business. Analyst inference
2. Compare future company updates on revenue and spending with the assumptions behind the target, if those assumptions are later made public. Analyst inference
3. Watch for further analyst rating or target changes, since they could indicate that views on Twist Bioscience’s expected value are shifting. Analyst inference

Evidence

• Original source link unavailable